MedPath

Study held to see the efffect of intake of Jyotishmatyadi Churn in treatment of Artavakshay

Not yet recruiting
Conditions
Oligomenorrhea, unspecified. Ayurveda Condition: ARTAVAKSHAYAH,
Registration Number
CTRI/2021/07/035110
Lead Sponsor
Roopali Sharnagat
Brief Summary

The Aim of the study is to see the Effectiveness of Jyotishmatyadi churna with lukewarm water in management of Artavakshaya patient. This study will be conducted on 60 patient showing sign and symptoms of artavakshaya in female of age group 18 year to 40 year. These patient  will  administered with 3 gm of jyotishmatyadi churna for 3 consecutive cycle and conclusion will be drawn on the basis of proper statistically method.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria
    1. Patient from age group 18-40 years old.
    1. Married & unmarried both women.
    1. Infrequent menses at interval longer than 35 days.
    1. Spotting, bleeding less than 2 days.
    1. PCOS having scanty bleeding ( Rotterdam crieteria positive).
Exclusion Criteria
    1. Lactating mother.
    1. Before Menarche.
    1. After Menopause.
    1. Pregnant women.
    1. Patients on oral contraceptive pills.
    1. Patients having any systemic disorders .
    1. Patients of artavakshaya having tubercular endometritis ,Asherman’s syndrome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Jyotishmatyadi churna is effective in management of Artavakshaya3 consecutive cycle
Secondary Outcome Measures
NameTimeMethod
study of artavakshaya in detail.3 consecutive menstrual cycle

Trial Locations

Locations (1)

Dr D Y Patil college of ayurveda and research center

🇮🇳

Pune, MAHARASHTRA, India

Dr D Y Patil college of ayurveda and research center
🇮🇳Pune, MAHARASHTRA, India
Roopali Sharnagat
Principal investigator
7987315696
roopalins1992@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.